Viveon Health Acquisition Corp.
VHAQ-UN
New York Stock Exchange Arca11.20
USD
-0.09
- -
Viveon Health Acquisition Corp.
VHAQ-UN
(New York Stock Exchange Arca)
Recent
price
11.20
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- Viveon Health Acquisition Corp. (VHAQ-UN) operates as a blank check company, or special purpose acquisition company, with no significant ongoing business operations; it focuses on effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more targets, primarily in the healthcare industry across North America. Incorporated in 2020 and headquartered at 3480 Peachtree Road NE, Suite 112, Atlanta, Georgia, the company trades its common stock, units, public warrants, and rights on the OTC Pink Marketplace following its delisting from NYSE American in July 2024 due to failure to complete an initial business combination within the required timeframe post-IPO. It functions as a subsidiary of Viveon Health LLC, led by CEO and Chairman Dr. Jagi Gill, with operations centered in the United States. The firm initially pursued a merger with Suneva Medical, Inc., a regenerative aesthetics company developing anti-aging products and medical devices such as Plasma IQ, announcing a definitive agreement in January 2022 that contemplated issuing 25 million shares for a pro forma equity value of around $370 million at the time, but terminated the deal in February 2023 citing material breaches by Suneva. Subsequently, Viveon entered into a letter of intent in March 2023 and a definitive merger agreement in April 2023 with Clearday, Inc. (OTCQX: CLRD), a San Antonio, Texas-based longevity technology company providing an integrated platform of robotic companion care, AI-driven technology, and senior adult care services targeting the global $1.75 trillion adult care market; the deal was amended in August 2023 to double Clearday's equity consideration to $500 million from $250 million, with up to five million additional earn-out shares tied to profitability milestones, and VHAQ reconfirmed its commitment to the transaction as recently as February 2024 amid ongoing efforts to clear regulatory hurdles and seek post-merger listing on a major exchange.